Business Standard

Friday, December 20, 2024 | 11:41 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

DCGI asks manufacturers to prevent black-marketing of Covid-19 drugs

Rajesh Bhushan, the Officer on Special Duty, Union Health Ministry, told an online media briefing Thursday that it has been noticed that certain drugs are not available freely in the market

covid, coronavirus, vaccine, drug, pharma
Premium

Drugs Controller General of India (DCGI) has written letters to companies manufacturing them with two specific suggestions

Press Trust of India
In order to prevent black-marketing and overpricing of Covid-19 drugs such as Remdesivir, India's drugs regulator DCGI has asked manufacturers to set up a helpline for patients and also put on their websites details of distributors and supply chain.

Rajesh Bhushan, the Officer on Special Duty, Union Health Ministry, told an online media briefing Thursday that it has been noticed that certain drugs are not available freely in the market.

Therefore, the Drugs Controller General of India (DCGI) has written letters to companies manufacturing them with two specific suggestions, he said.

"First suggestion was that these companies must put in place a 24x7

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in